North Carolina Heart and Vascular Specialists, UNC/Rex Healthcare, 1505 SW Cary Parkway, Suite 300, Cary, NC, 27511, USA.
BMC Cardiovasc Disord. 2020 Feb 4;20(1):54. doi: 10.1186/s12872-020-01348-w.
Neurogenic orthostatic hypotension, a sustained decrease in blood pressure upon standing, is caused by autonomic nervous system failure and characterized by an insufficient increase in heart rate needed to maintain blood pressure upon standing. In this case, neurogenic orthostatic hypotension symptoms preceded a diagnosis of Parkinson disease. A diagnosis of underlying neurogenic orthostatic hypotension significantly changed the course of treatment for this patient.
An 84-year-old woman was referred to a cardiologist by her primary care practitioner for evaluation of exertional dyspnea and chest pain upon walking a few feet. Her medical history included hypertension, hypothyroidism, and osteoarthritis. Based on her continued symptoms, the patient underwent 2 cardiac catheterizations for coronary artery stenosis. After the catheterizations, exertional dyspnea and chest pain continued, and subsequently, dysphagia to solid foods and episodic dizziness developed. Orthostatic evaluation showed a supine blood pressure of 150/80 mmHg with a heart rate of 70 beats per min. Upon standing for 3 min, the patient's blood pressure decreased to 110/74 mmHg with a heart rate of 76 beats per min. The diagnostic criteria for orthostatic hypotension were met, and the lack of an adequate compensatory heart rate increase upon standing was consistent with a neurogenic cause (ie, neurogenic orthostatic hypotension), which was supported by tilt-table testing results. Although nonpharmacologic treatments were initially successful, episodes of lightheadedness, chest pain, and dyspnea upon standing became more frequent, and the patient was prescribed droxidopa (200 mg; 3 times daily). Droxidopa significantly improved her symptoms, with the patient reporting resolution of her chest pain and significant improvement of dyspnea and dizziness. She was diagnosed with Parkinson disease approximately 6 months later.
This case highlights the importance of evaluating and identifying potential causes of symptoms of cardiovascular disease when persistent symptoms do not improve after cardiac interventions. This case complements findings demonstrating that signs of autonomic failure, such as neurogenic orthostatic hypotension, may precede the motor symptoms of Parkinson disease. Importantly, this case provides real-world evidence for the efficacy of droxidopa to treat the symptoms of neurogenic orthostatic hypotension, after an appropriate diagnosis.
神经源性直立性低血压是一种由自主神经系统衰竭引起的血压持续下降,其特征是站立时心率增加不足,无法维持血压。在这种情况下,神经源性直立性低血压的症状先于帕金森病的诊断。潜在神经源性直立性低血压的诊断显著改变了患者的治疗过程。
一位 84 岁女性因行走几步后出现劳力性呼吸困难和胸痛,由初级保健医生转介至心脏病专家。她的病史包括高血压、甲状腺功能减退症和骨关节炎。鉴于她持续存在症状,患者接受了 2 次用于评估冠状动脉狭窄的心脏导管插入术。导管插入术后,劳力性呼吸困难和胸痛仍持续存在,随后出现吞咽固体食物困难和间歇性头晕。直立评估显示仰卧位血压为 150/80mmHg,心率为 70 次/分。站立 3 分钟后,患者的血压降至 110/74mmHg,心率为 76 次/分。直立性低血压的诊断标准得到满足,站立时心率增加不足以代偿,符合神经源性原因(即神经源性直立性低血压),倾斜试验结果支持这一诊断。虽然最初的非药物治疗取得了成功,但站立时头晕、胸痛和呼吸困难的发作变得更加频繁,因此患者开始服用屈昔多巴(200mg;每日 3 次)。屈昔多巴显著改善了她的症状,患者报告胸痛缓解,呼吸困难和头晕明显改善。大约 6 个月后,她被诊断为帕金森病。
本病例强调了在心脏介入治疗后持续存在的症状没有改善时,评估和确定心血管疾病症状潜在原因的重要性。本病例补充了发现,表明自主神经衰竭的迹象,如神经源性直立性低血压,可能先于帕金森病的运动症状出现。重要的是,本病例为 droxidopa 在适当诊断后治疗神经源性直立性低血压症状的疗效提供了真实世界的证据。